READ THIS – If You Missed Out On The AI Boom

Adam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.”

Click on Adam's shiny forehead for more details.

CRL Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 1.30%

Insider Buying (Last 12 Months): $1,447,729.04

Insider Selling (Last 12 Months): $5,481,396.41

Charles River Laboratories International Insider Trading History Chart

Charles River Laboratories International Share Price & Price History

^$235.34

▼ -0.97 (-0.41%)

As of 05/8/2024 01:00 AM ET

Days: 30 | 90 | 365

The Best AI Stock to Own in the World Today is Trading for Just $25

From Banyan Hill Publishing | Ad

“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.

See how you can invest alongside him

Charles River Laboratories International Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/29/2024	Victoria L Creamer	EVP	Sell	5,000	$253.70	$1,268,500.00	13,550
2/22/2024	William D Barbo	VP	Sell	4,050	$248.50	$1,006,425.00	22,879
2/15/2024	Shannon M. Parisotto	EVP	Sell	5,882	$241.20	$1,418,738.40	2,596
11/20/2023	Birgit Girshick	COO	Buy	1,322	$187.82	$248,298.04	44,449
11/14/2023	James C Foster	CEO	Buy	5,620	$178.05	$1,000,641.00	202,643
8/24/2023	Richard F. Wallman	Director	Buy	1,000	$198.79	$198,790.00	1,000
8/10/2023	Joseph W. LaPlume	EVP	Sell	700	$216.52	$151,564.00	24,983
8/10/2023	Michael Gunnar Knell	CAO	Sell	1,471	$216.54	$318,530.34	9,940
8/10/2023	William D Barbo	VP	Sell	5,763	$217.24	$1,251,954.12	3,592
5/15/2023	Joseph W. LaPlume	EVP	Sell	345	$190.39	$65,684.55	24,026
2/16/2023	Birgit Girshick	COO	Sell	3,205	$254.39	$815,319.95	41,038
2/16/2023	Shannon M. Parisotto	EVP	Sell	4,558	$254.41	$1,159,600.78	6,010
2/15/2023	James C Foster	CEO	Sell	20,000	$250.00	$5,000,000.00	216,594
12/1/2022	Joseph W. LaPlume	EVP	Sell	6,409	$224.25	$1,437,218.25	20,232
11/16/2022	Michael Gunnar Knell	CAO	Sell	855	$248.59	$212,544.45	6,438
11/15/2022	Shannon M. Parisotto	EVP	Sell	2,279	$249.90	$569,522.10	2,499
11/4/2022	Joseph W. LaPlume	EVP	Sell	534	$216.36	$115,536.24	20,232
8/5/2022	Joseph W. LaPlume	EVP	Sell	200	$226.13	$45,226.00	20,766
5/9/2022	George Massaro	Director	Sell	178	$230.96	$41,110.88	4,677
2/22/2022	James C Foster	CEO	Sell	17,436	$288.67	$5,033,250.12
2/22/2022	Joseph W. LaPlume	EVP	Sell	396	$290.83	$115,168.68
2/18/2022	Joseph W. LaPlume	EVP	Sell	1,143	$291.80	$333,527.40
2/15/2022	James C Foster	CEO	Sell	20,000	$315.46	$6,309,200.00
9/13/2021	Birgit Girshick	VP	Sell	81	$442.19	$35,817.39	30,025
8/31/2021	George Massaro	Director	Sell	2,539	$442.48	$1,123,456.72	4,855
8/16/2021	Victoria L. Creamer	EVP	Sell	6,917	$415.24	$2,872,215.08	8,531
8/9/2021	David Ross Smith	CFO	Sell	1,750	$407.40	$712,950.00
8/6/2021	Deborah Turner Kochevar	Director	Sell	3,526	$406.43	$1,433,072.18
8/6/2021	James C. Foster	CEO	Sell	10,000	$401.79	$4,017,900.00	212,299
8/6/2021	Joseph W. LaPlume	EVP	Sell	3,700	$402.21	$1,488,177.00
8/6/2021	William D. Barbo	VP	Sell	12,387	$402.82	$4,989,731.34	4,371
6/3/2021	Michael Gunnar Knell	CAO	Sell	800	$329.76	$263,808.00	4,563
6/1/2021	James C Foster	CEO	Sell	9,577	$332.23	$3,181,766.71	224,376
5/11/2021	George Massaro	Director	Sell	371	$320.06	$118,742.26	5,696
5/7/2021	James C Foster	CEO	Sell	7,500	$343.17	$2,573,775.00	221,088

Fidelity, Bezos, Goldman Bet Big on Tiny Biotech

From Behind the Markets | Ad

Are you ready for a major shift in the investment world? There's a new drug The Wall Street Journal is calling the "King Kong" of drugs.

Don't miss out on the "next Ozempic" >>>

SEC Filings (Institutional Ownership Changes) for Charles River Laboratories International (NYSE:CRL)

98.91% of Charles River Laboratories International stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Charles River Laboratories International Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/8/2024	BNP PARIBAS ASSET MANAGEMENT Holding S.A.	204,044	$55.29M	0.1%	-19.9%	0.396%
5/8/2024	Entropy Technologies LP	3,390	$0.92M	0.1%	-42.6%	0.007%
5/8/2024	J.P. Marvel Investment Advisors LLC	39,486	$10.70M	1.9%	+1.8%	0.077%
5/8/2024	William Blair Investment Management LLC	364,614	$98.79M	0.3%	-1.6%	0.708%
5/8/2024	Bleakley Financial Group LLC	825	$0.22M	0.0%	N/A	0.002%
5/8/2024	ProShare Advisors LLC	9,392	$2.55M	0.0%	-18.3%	0.018%
5/8/2024	US Bancorp DE	21,800	$5.91M	0.0%	-11.6%	0.042%
5/8/2024	Russell Investments Group Ltd.	37,074	$10.05M	0.0%	+31.9%	0.072%
5/8/2024	Qsemble Capital Management LP	3,672	$1M	0.2%	N/A	0.007%
5/8/2024	QRG Capital Management Inc.	1,047	$0.28M	0.0%	N/A	0.002%
5/8/2024	Headlands Technologies LLC	150	$41K	0.0%	N/A	0.000%
5/7/2024	Meeder Asset Management Inc.	335	$91K	0.0%	-62.0%	0.001%
5/7/2024	Regency Capital Management Inc. DE	17,930	$4.86M	2.9%	+14.5%	0.035%
5/7/2024	Quantum Private Wealth LLC	799	$0.22M	0.1%	N/A	0.002%
5/7/2024	Sei Investments Co.	575,349	$155.89M	0.2%	+1.3%	1.117%
5/7/2024	Atomi Financial Group Inc.	1,996	$0.54M	0.0%	N/A	0.004%
5/7/2024	Anchor Capital Advisors LLC	106,061	$28.74M	0.8%	-5.2%	0.206%
5/7/2024	Montag A & Associates Inc.	8,221	$2.23M	0.1%	N/A	0.016%
5/7/2024	Susquehanna Portfolio Strategies LLC	10,600	$2.87M	0.1%	-17.2%	0.021%
5/7/2024	Heartland Advisors Inc.	26,547	$7.19M	0.4%	N/A	0.052%
5/7/2024	Swiss National Bank	153,600	$41.62M	0.0%	-4.2%	0.298%
5/7/2024	Forsta AP Fonden	10,300	$2.79M	0.0%	+17.0%	0.020%
5/7/2024	TimesSquare Capital Management LLC	135,003	$36.58M	0.5%	+324.1%	0.262%
5/7/2024	Oppenheimer Asset Management Inc.	43,314	$11.74M	0.2%	-2.3%	0.084%
5/7/2024	Oppenheimer & Co. Inc.	1,745	$0.47M	0.0%	N/A	0.003%
5/7/2024	SG Americas Securities LLC	16,362	$4.43M	0.0%	+23.4%	0.032%
5/7/2024	Empowered Funds LLC	3,344	$0.91M	0.0%	+10.0%	0.006%
5/7/2024	Stokes Family Office LLC	6,934	$1.88M	0.2%	+36.1%	0.013%
5/6/2024	Envestnet Portfolio Solutions Inc.	9,631	$2.61M	0.0%	+2.1%	0.019%
5/6/2024	Empirical Finance LLC	1,272	$0.35M	0.0%	+5.3%	0.002%
5/6/2024	Mawer Investment Management Ltd.	45,599	$12.36M	0.1%	+75.2%	0.089%
5/6/2024	Texas Permanent School Fund Corp	10,602	$2.87M	0.0%	+3.0%	0.021%
5/4/2024	Geneva Capital Management LLC	16,518	$4.48M	0.1%	+1.5%	0.032%
5/4/2024	Geneos Wealth Management Inc.	7,629	$2.07M	0.1%	+52.2%	0.015%
5/3/2024	FDx Advisors Inc.	2,621	$0.71M	0.1%	-28.0%	0.005%
5/3/2024	Chevy Chase Trust Holdings LLC	28,413	$7.70M	0.0%	-0.8%	0.055%
5/3/2024	BI Asset Management Fondsmaeglerselskab A S	1,612	$0.44M	0.0%	-27.3%	0.003%
5/3/2024	Meridian Management Co.	9,346	$2.53M	0.7%	+1.4%	0.018%
5/2/2024	Mutual of America Capital Management LLC	6,718	$1.82M	0.0%	-2.0%	0.013%
5/2/2024	Daiwa Securities Group Inc.	5,063	$1.37M	0.0%	+11.3%	0.010%
5/2/2024	Tokio Marine Asset Management Co. Ltd.	1,986	$0.54M	0.0%	+23.9%	0.004%
5/2/2024	Iridian Asset Management LLC CT	24,404	$6.61M	1.3%	-21.6%	0.047%
5/1/2024	Janney Montgomery Scott LLC	46,006	$12.47M	0.0%	+5.3%	0.089%
5/1/2024	BNP Paribas Financial Markets	67,148	$18.19M	0.0%	+45.3%	0.130%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	10,713	$2.90M	0.0%	-27.4%	0.021%
5/1/2024	Baillie Gifford & Co.	67,534	$18.30M	0.0%	-3.8%	0.131%
5/1/2024	Sequoia Financial Advisors LLC	13,551	$3.67M	0.0%	-3.9%	0.026%
4/30/2024	Norden Group LLC	1,836	$0.50M	0.0%	+60.3%	0.004%
4/30/2024	Van ECK Associates Corp	55,637	$15.08M	0.0%	-3.5%	0.108%
4/30/2024	Concord Wealth Partners	259	$70K	0.0%	+362.5%	0.001%
4/30/2024	Argent Capital Management LLC	147,252	$39.90M	1.2%	+137.7%	0.286%
4/29/2024	Commonwealth Equity Services LLC	21,489	$5.82M	0.0%	+2.2%	0.042%
4/29/2024	Principal Financial Group Inc.	172,722	$46.80M	0.0%	+13.2%	0.335%
4/29/2024	Benjamin F. Edwards & Company Inc.	695	$0.19M	0.0%	-8.2%	0.001%
4/29/2024	Mn Services Vermogensbeheer B.V.	20,700	$5.61M	0.0%	N/A	0.040%
4/26/2024	Securian Asset Management Inc.	2,986	$0.81M	0.0%	-7.3%	0.006%
4/26/2024	Riverbridge Partners LLC	303,778	$82.31M	1.0%	+1.0%	0.590%
4/26/2024	Mitchell & Pahl Private Wealth LLC	3,092	$0.84M	0.4%	+4.5%	0.006%
4/25/2024	New York State Teachers Retirement System	53,033	$14.37M	0.0%	-3.8%	0.103%
4/25/2024	WCM Investment Management LLC	5,934	$1.61M	0.0%	+1.5%	0.012%
4/25/2024	Equitable Trust Co.	2,466	$0.67M	0.0%	+8.1%	0.005%
4/25/2024	Zurcher Kantonalbank Zurich Cantonalbank	9,486	$2.57M	0.0%	-3.8%	0.018%
4/25/2024	Fjarde AP Fonden Fourth Swedish National Pension Fund	6,530	$1.77M	0.0%	+38.1%	0.013%
4/24/2024	Leavell Investment Management Inc.	4,000	$1.08M	0.1%	-13.0%	0.008%
4/24/2024	Simplicity Wealth LLC	825	$0.22M	0.0%	N/A	0.002%
4/24/2024	Spire Wealth Management	1,135	$0.31M	0.0%	-7.8%	0.002%
4/24/2024	Assenagon Asset Management S.A.	38,256	$10.37M	0.0%	+50.1%	0.074%
4/23/2024	Bell Bank	1,501	$0.41M	0.0%	-12.5%	0.003%
4/23/2024	Eads & Heald Wealth Management	1,951	$0.53M	0.2%	-5.9%	0.004%
4/23/2024	Louisiana State Employees Retirement System	3,000	$0.81M	0.0%	-3.2%	0.006%
4/23/2024	Amalgamated Bank	10,713	$2.90M	0.0%	-32.4%	0.021%
4/23/2024	New Mexico Educational Retirement Board	2,600	$0.70M	0.0%	-3.7%	0.005%
4/23/2024	Fifth Third Bancorp	12,686	$3.44M	0.0%	+5.2%	0.025%
4/23/2024	McAdam LLC	850	$0.23M	0.0%	-7.8%	0.002%
4/23/2024	Raymond James Financial Services Advisors Inc.	5,508	$1.49M	0.0%	+87.3%	0.011%
4/23/2024	Stonegate Investment Group LLC	976	$0.26M	0.0%	N/A	0.002%
4/22/2024	Byrne Asset Management LLC	534	$0.15M	0.1%	+54.8%	0.001%
4/22/2024	Raymond James & Associates	248,348	$67.29M	0.0%	+1.9%	0.482%
4/22/2024	Lawson Kroeker Investment Management Inc. NE	55,158	$14.95M	2.8%	-0.3%	0.107%
4/22/2024	Professional Advisory Services Inc.	55,096	$14.93M	2.0%	-16.0%	0.107%
4/22/2024	EFG Asset Management Americas Corp.	750	$0.20M	0.1%	-27.1%	0.001%
4/22/2024	IFM Investors Pty Ltd	9,586	$2.60M	0.0%	N/A	0.019%
4/22/2024	Everpar Advisors LLC	2,311	$0.63M	0.4%	-40.5%	0.004%
4/19/2024	First Trust Direct Indexing L.P.	779	$0.21M	0.0%	N/A	0.002%
4/19/2024	Norden Group LLC	31,399	$8.51M	0.1%	+2,642.3%	0.061%
4/19/2024	Sumitomo Mitsui Trust Holdings Inc.	118,098	$32M	0.0%	-1.6%	0.229%
4/19/2024	Handelsinvest Investeringsforvaltning	1,518	$0.41M	0.2%	-34.2%	0.003%
4/18/2024	Woodmont Investment Counsel LLC	805	$0.22M	0.0%	N/A	0.002%
4/18/2024	Allspring Global Investments Holdings LLC	1,118,816	$303.14M	0.5%	-4.0%	2.172%
4/18/2024	Congress Wealth Management LLC DE	54,316	$14.72M	0.3%	+0.9%	0.105%
4/18/2024	LVW Advisors LLC	2,836	$0.77M	0.1%	-2.1%	0.006%
4/17/2024	Dumont & Blake Investment Advisors LLC	4,415	$1.20M	0.3%	+1.4%	0.009%
4/16/2024	WD Rutherford LLC	14,564	$3.95M	2.0%	-1.1%	0.028%
4/16/2024	Norris Perne & French LLP MI	128,630	$34.85M	2.5%	-2.5%	0.250%
4/16/2024	Thrive Wealth Management LLC	1,076	$0.29M	0.1%	+11.4%	0.002%
4/16/2024	Cardinal Capital Management	9,822	$2.66M	0.4%	+16.2%	0.019%
4/15/2024	Sunbelt Securities Inc.	258	$70K	0.0%	+1,072.7%	0.001%
4/12/2024	Riverview Trust Co	368	$100K	0.1%	N/A	0.001%
4/12/2024	CGN Advisors LLC	7,920	$2.15M	0.3%	+12.6%	0.015%
4/12/2024	Harbor Investment Advisory LLC	594	$0.16M	0.0%	-37.1%	0.001%

Data available starting January 2016

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of preclinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies. It also provides contract vivarium operation services to biopharmaceutical clients. The company was founded in 1947 and is headquartered in Wilmington, Massachusetts.

Today's Range

Now: $235.34

$233.14

$236.82

50 Day Range

MA: $251.18

$226.78

$273.43

52 Week Range

Now: $235.34

$161.65

$275.00

Volume

610,304 shs

Average Volume

543,878 shs

Market Capitalization

$12.12 billion

P/E Ratio

25.55

Dividend Yield

N/A

Beta

1.44

Who are the company insiders with the largest holdings of Charles River Laboratories International?: Charles River Laboratories International's top insider investors include:
James C Foster (CEO)
Birgit Girshick (COO)
Joseph W Laplume (EVP)
William D Barbo (VP)
Victoria L Creamer (EVP)
Michael Gunnar Knell (CAO)
Shannon M Parisotto (EVP)
George Massaro (Director)
Richard F Wallman (Director)
Learn More about top insider investors at Charles River Laboratories International.
Who are the major institutional investors of Charles River Laboratories International?: Charles River Laboratories International's top institutional investors include:
Allspring Global Investments Holdings LLC — 2.17%
Sei Investments Co. — 1.12%
Congress Asset Management Co. MA — 0.88%
William Blair Investment Management LLC — 0.71%
Riverbridge Partners LLC — 0.59%
Raymond James & Associates — 0.48%
Learn More about top institutional investors of Charles River Laboratories International stock.
Which major investors are selling Charles River Laboratories International stock?: During the last quarter, CRL stock was sold by these institutional investors:
BNP PARIBAS ASSET MANAGEMENT Holding S.A.
Allspring Global Investments Holdings LLC
Congress Asset Management Co. MA
Professional Advisory Services Inc.
Iridian Asset Management LLC CT
Swiss National Bank
William Blair Investment Management LLC
Anchor Capital Advisors LLC
In the last year, company insiders that have sold Charles River Laboratories International company stock include:
James C Foster (CEO)
Birgit Girshick (COO)
Joseph W Laplume (EVP)
William D Barbo (VP)
Victoria L Creamer (EVP)
Learn More investors selling Charles River Laboratories International stock.
Which major investors are buying Charles River Laboratories International stock?: During the previous quarter, CRL stock was bought by institutional investors including:
TimesSquare Capital Management LLC
Confluence Investment Management LLC
Argent Capital Management LLC
D. Scott Neal Inc.
Global Assets Advisory LLC
Norden Group LLC
Heartland Advisors Inc.
BNP Paribas Financial Markets
During the last year, these company insiders have bought Charles River Laboratories International stock:
James C Foster (CEO)
Birgit Girshick (COO)
Joseph W Laplume (EVP)
Learn More investors buying Charles River Laboratories International stock.